Literatur
-
1
Heiligenhaus A, Niewerth M, Ganser G. et al .
Prevalence and complications of uveitis in juvenile
idiopathic arthritis in a population-based nation-wide study in Germany:
suggested modification of the current screening guidelines.
Rheumatology (Oxford).
2007;
46 (6)
1015-1019
-
2
Al-Matar M J, Petty R E, Tucker L B. et al .
The early pattern of joint involvement predicts disease
progression in children with oligoarticular (pauciarticular) juvenile
rheumatoid arthritis.
Arthritis Rheum.
2002;
46 (10)
2708-2715
-
3
Padeh S, Passwell J H.
Intraarticular corticosteroid injection in the management of
children with chronic arthritis.
Arthritis Rheum.
1998;
41 (7)
1210-1214
-
4
Ruperto N, Murray K J, Gerloni V. et al .
A randomized trial of parenteral methotrexate comparing an
intermediate dose with a higher dose in children with juvenile idiopathic
arthritis who failed to respond to standard doses of methotrexate.
Arthritis Rheum.
2004;
50
2191-2201
-
5 Horneff G. et al .Experience with Etanercept in 1014 patients with juvenile
idiopathic arthritis. EULAR Congress Kopenhagen. 2009
-
6
Lovell D J. et al .
Adalimumab with or without methotrexate in juvenile
rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group;
Pediatric Rheumatology International Trials Organisation.
N Engl J Med.
2008;
359 (8)
810-820
-
7
Ruperto N, Lovell D J, Cuttica R. et al .
A randomized, placebo-controlled trial of infliximab plus
methotrexate for the treatment of polyarticular-course juvenile rheumatoid
arthritis. Paediatric Rheumatology International Trials Organisation; Pediatric
Rheumatology Collaborative Study Group.
Arthritis Rheum.
2007;
56 (9)
3096-3106
-
8
Lahdenne P, Vahasalo P, Honkanen V.
Infliximab or etanercept in the treatment of children with
refractory juvenile idiopathic arthritis: an open label study.
Ann Rheum Dis.
2003;
62 (3)
245-247
-
9
Ruperto N, Lovell D J, Quartier P. et al .
Abatacept in children with juvenile idiopathic arthritis: a
randomised, double-blind, placebo-controlled withdrawal trial. Paediatric
Rheumatology International Trials Organization; Pediatric Rheumatology
Collaborative Study Group.
Lancet.
2008;
372 (9636)
383-391
-
10
García-Consuegra Molina J. et al .
Macrophage activation syndrome and juvenile idiopathic
arthritis. A multicenter study.
An Pediatr (Barc.).
2008;
68 (2)
110-116
-
11
Singh G, Athreya B H, Fries J F. et al .
Measurement of health status in children with juvenile
rheumatoid arthritis.
Arthritis Rheum.
1994;
37 (12)
1761-1769
-
12
Silverman E D, Cawkwell G D, Lovell D J. et al .
Intravenous immunoglobulin in the treatment of systemic
juvenile rheumatoid arthritis: a randomized placebo controlled trial. Pediatric
Rheumatology Collaborative Study Group.
J Rheumatol.
1994;
21 (12)
2353-2358
-
13
Gattorno M, Piccini A, Lasiglie D. et al .
The pattern of response to anti-interleukin-1 treatment
distinguishes two subsets of patients with systemic-onset juvenile idiopathic
arthritis.
Arthritis Rheum.
2008;
58 (5)
1505-1515
-
14
Yokota S, Imagawa T, Mori M. et al .
Efficacy and safety of tocilizumab in patients with
systemic-onset juvenile idiopathic arthritis: a randomised, double-blind,
placebo-controlled, withdrawal phase III trial.
Lancet.
2008;
371 (9617)
998-1006
-
15
Brinkman D M, de Kleer I M, ten Cate R. et al .
Autologous stem cell transplantation in children with severe
progressive systemic or polyarticular juvenile idiopathic arthritis: long-term
follow-up of a prospective clinical trial.
Arthritis Rheum.
2007;
56 (7)
2410-2421
-
16
Ravelli A, De Benedetti F, Viola S. et al .
Macrophage activation syndrome in systemic juvenile
rheumatoid arthritis successfully treated with cyclosporine.
J Pediatr.
1996;
128 (2)
275-278
-
17
Roberton D M, Cabral D A, Malleson P N. et al .
Juvenile psoriatricarthritis: follw-up and evaluation of
diagnostic criteria.
J Rheumatol.
1996;
23 (1)
166-170
-
18
Mease P J, Kivitz A J, Burch F X. et al .
Etanercept in the treatment of psoriatic arthritis and
psoriasis: a randomised trial.
Arthritis Rheum.
2004;
50 (7)
2264-2272
Frank Weller
Prof.-Hess-Kinderklinik Klinikum Bremen-Mitte
St.-Jürgen-Str. 1
28177 Bremen
Phone: 0421/497 54 11
Fax: 0421/497 33 11
Email: frank.weller@klinikum-bremen-mitte.de
